Panacea Biotec Ltd. benchmarking: Performance to industry peers

Financial

	Panacea Biotec	Gufic Biosciences	Novartis India
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	6.0 .	n/a	n/a
R&D as a % of Total Sales	9.86 %	1.28 %	n/a
Financials
5 yr Average ROE	37.52 %	16.89 %	8.11 %
5yr average Equity Multiplier	0.36	2.16	2.72
5yr Average Asset Turnover Ratio	0.41	0.75	0.18
5yr Avg Net Profit Margin	26.1 %	10.24 %	17.12 %
Price to Book	4.16	5.85	4.84
P/E	0.0	60.58	42.49
5yr Avg Cash Conversion Cycle	-170.26 Days	-15.25 Days	-23.33 Days
Inventory Days	120.03 Days	71.73 Days	44.27 Days
Days Receivable	42.2 Days	106.89 Days	38.18 Days
Days Payable	325.14 Days	179.29 Days	124.28 Days
5yr Average Interest Coverage Ratio	2.7	8.9	65.43
5yr Avg ROCE	-2.79 %	17.89 %	5.91 %
5yr Avg Operating Profit Margin	-3.85 %	18.12 %	15.15 %
5 yr average Debt to Equity	-0.69	0.67	0.0
5yr CAGR Net Profit	-43.68 %	-2.66 %	37.01 %
5yr Average Return on Assets	9.32 %	7.7 %	3.13 %
Shareholdings
Promoter Holding	72.48 %	72.5 %	70.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-1.11 %	-2.5 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	2.6 %	0.0

Business

	Panacea Biotec	Gufic Biosciences	Novartis India
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Anti - Diabetes 43.91 Gastro Intestinal 13.47 Pain Management 12.87 Anti-Neoplastics 8.18 Vitamins / Minerals / Nutrients 6.09 Respiratory Systems 5.39 Vaccines 5.39 Blood Related 2.99 Hormones 0.6 Others 1.11	-	-
Product Wise Break-Up	Product Wise Break-Up Vaccines 64.74 Formulations 35.26 Research and Development 0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0 0	Product Wise Break-Up Domestic Pharmaceuticals 50.0 CMO 30.0 0 Vaccines 0 Active Pharmaceutical Ingredient (API) 5.0 Research and Development 0 Anti-fungals 0 Formulations 0 International 15.0 Cardiovascular 0 Anti-bacterials 0 Proton pump inhibitors 0 Muscle Relaxants 0	Product Wise Break-Up Domestic 0 CMO 0 Wholesale of pharmaceuticals and medical goods 100.0 Vaccines 0 API 0 Research and Development 0 Anti-fungals 0 Formulations 0 International 0 Cardiovascular 0 Anti-bacterials 0 Proton pump inhibitors 0 Muscle Relaxants 0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 86.09 India 13.91 South America 0 Australia 0 North America 0 Europe 0 Asia 0 Africa 0	Location Wise Break-Up Asia Pacific 6.04 India 79.83 Rest of the World 0 Australia 0.08 South America 2.37 Europe 7.54 North America 1.19 Africa 2.95	Location Wise Break-Up Asia 0 India 100.0 Rest of the World 0 Australia 0 South America 0 Europe 0 North America 0 Africa 0
Operating Profit Break-Up	Operating Profit Break-Up Others 100	-	-
Capex	Capex Vaccines 69.46 Formulations 30.54 Real estate 0	-	-
Brand Wise Break-Up	Brand Wise Break-Up PanGraf 21.0 Glizid Family 19.0 Sitcom Family 10.0 Mycept & Mycept 5.0 Livoluk Family 4.0 Panimun Bioral 4.0 PacliAll 1.0 Thank OD Family 0 Nimulid Family 0 Others 36.0	-	-
Asset Break-Up	Asset Break-Up Vaccines 68.94 Formulations 31.06 Real Estate 0	-	-

Panacea Biotec Ltd.

Panacea Biotec Ltd.

Financial

Business

SIGN UP FOR FREE